4.6 Article

Long noncoding RNA are aberrantly expressed in vivo in the cystic fibrosis bronchial epithelium

期刊

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.biocel.2014.02.022

关键词

Cystic fibrosis bronchial epithelial cells; IncRNA; XIST; TLR8

资金

  1. Health Research Board in Ireland [PHD/2007/11]
  2. ERS/GlaxoSmithKline Award for Rare Pulmonary Disease

向作者/读者索取更多资源

Long non-coding RNAs (lncRNAs) have emerged recently as key regulatory molecules with diverse roles at almost every level of the regulation of gene expression. The roles of these RNAs in the pathogenesis of cystic fibrosis (CF); a lethal multisystem, autosomal recessive disorder have yet to be explored. Our aim was to examine the expression profile of lncRNA, in the airway epithelium of people with CF. We examined the expression of 30,586 lncRNAs by microarray (Human LncRNA Array v3.0, Arraystar, Inc.), in vivo in bronchial cells isolated from endobronchial brushings obtained from CF and non-CF individuals. In total, we identified 1,063 lncRNAs with differential expression between CF and non-CF individuals (fold change >= 3, p <= 0.001). The microarray also contained probes for similar to 26,109 protein coding transcripts, of which 720 were differentially expressed between CF and non-CF brush samples (fold change >= 3, p <= 0.001). Confirmation of a selection of differentially expressed coding mRNA and lncRNA transcripts such as XIST and TLR8 was achieved using qRT-PCR. Gene ontology bioinformatics analysis highlighted that many processes over-represented in the CF bronchial epithelium are related to inflammation. These data show a significantly altered lncRNA and mRNA expression profile in CF bronchial cells in vivo. Dysregulation of some of these lncRNAs may play important roles in the chronic infection and inflammation that exists in the lungs of people with CF. (C) 2014 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency

Malin Fromme, Carolin Schneider, Vitor Pereira, Karim Hamesch, Monica Pons, Matthias C. Reichert, Federica Benini, Paul Ellis, Katrine Thorhauge, Mattias Mandorfer, Barbara Burbaum, Vivien Woditsch, Joanna Chorostowska-Wynimko, Jef Verbeek, Frederik Nevens, Joan Genesca, Marc Miravitlles, Alexa Nunez, Benedikt Schaefer, Heinz Zoller, Sabina Janciauskiene, Nelia Abreu, Luis Jasmins, Rui Gaspar, Rodrigo Liberal, Guilherme Macedo, Ravi Mahadeva, Catarina Gomes, Kai Markus Schneider, Michael Trauner, Aleksander Krag, Bibek Gooptu, Douglas Thorburn, Aileen Marshall, John R. Hurst, David A. Lomas, Frank Lammert, Nadine T. Gaisa, Virginia Clark, William Griffiths, Christian Trautwein, Alice M. Turner, Noel G. McElvaney, Pavel Strnad

Summary: Alpha-1 antitrypsin deficiency (AATD) is a common genetic disorder caused by mutations in the alpha-1 antitrypsin (AAT) gene. Different AATD genotypes have varying degrees of liver and biliary abnormalities, with the Pi*ZZ genotype showing the highest occurrence of liver fibrosis/cirrhosis and primary liver cancer. Male sex, age >= 50 years, obesity and the presence of diabetes were associated with significant liver fibrosis.
Article Respiratory System

Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold

Alessandro N. Franciosi, Daniel Fraughen, Tomas P. Carroll, Noel G. McElvaney

Summary: Alpha-1 antitrypsin deficiency is the only known monogenic cause of COPD. The only condition-specific treatment for COPD associated with this deficiency is intravenous administration of purified human alpha-1 antitrypsin. The use of 11 mu M threshold as a determinant of clinical risk for COPD has been questioned, and genotype is considered a more reliable indicator. New risk assessment models are needed for individuals diagnosed with alpha-1 antitrypsin deficiency to optimize treatment goals.

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Polymer Science

Ion-Triggered Hydrogels Self-Assembled from Statistical Copolypeptides

Bing Wu, Saltuk B. Hanay, Scott D. Kimmins, Sally-Ann Cryan, Daniel Hermida Merino, Andreas Heise

Summary: The ion-induced gelation behavior of statistical copolypeptides comprising lysine and tyrosine is studied, and it is found that the gelation mechanism is related to the formation of stable intermolecular beta-sheet secondary structures induced by the presence of salt ions as well as the aggregation of an alpha-helix between the copolypeptides. The diffusion and mechanical properties of the hydrogels can be tuned by adjusting the polypeptide chain length and ion strength.

ACS MACRO LETTERS (2022)

Article Biochemistry & Molecular Biology

Systematic Study of Enzymatic Degradation and Plasmid DNA Complexation of Mucus Penetrating Star-Shaped Lysine/Sarcosine Polypept(o)ides with Different Block Arrangements

Dimitrios Skoulas, Sarinj Fattah, Dandan Wang, Sally-Ann Cryan, Andreas Heise

Summary: 8-arm star polypeptides consisting of cationic polylysine and hydrophilic polysarcosine blocks were synthesized. The enzymatic hydrolysis and disintegration of the polypeptides showed a strong dependence on structural arrangements. The polyplexes formed by the polypeptides were capable of complexing plasmid DNA, had sizes around or below 200 nm, and could transport through mucus.

MACROMOLECULAR BIOSCIENCE (2022)

Article Pharmacology & Pharmacy

Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis

Ahmad Z. Bahlool, Sarinj Fattah, Andrew O'Sullivan, Brenton Cavanagh, Ronan MacLoughlin, Joseph Keane, Mary P. O'Sullivan, Sally-Ann Cryan

Summary: Developing new treatment strategies for multidrug-resistant tuberculosis is a global challenge. This study focuses on a host-directed therapy using All Trans Retinoic Acid (ATRA)-loaded nanoparticles for targeted tuberculosis treatment. The efficacy studies showed a dose-dependent reduction in the growth of Mycobacterium tuberculosis, and the nanoparticles were efficiently delivered into macrophages. This targeted therapy could potentially enhance current treatment options for tuberculosis.

PHARMACEUTICS (2022)

Letter Dermatology

Mondor disease: an uncommon complication in dermatological surgery

Elizabeth Keeling, Heba Bosbait, Caitriona Hackett, Asad Salim, Maureen Connolly, Anne-Marie Tobin, Kevin Molloy

Summary: We report a rare case of Mondor disease following elliptical excision of a naevus on the chest wall. The condition is a superficial thrombophlebitis that usually occurs on the anterolateral thoracoabdominal wall. It can be idiopathic or secondary to trauma, breast malignancy, hypercoagulable states, or iatrogenic causes, with breast surgery being the most common. Mondor disease typically resolves within weeks.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2023)

Letter Dermatology

Systemic AA amyloidosis in hidradenitis suppurativa: Should we be screening?

Julie Mac Mahon, Gregg Murray, Yvonne McCartney, Stephen Crowther, Anne-Marie Tobin, Kevin Molloy

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Biochemistry & Molecular Biology

Long Non-Coding RNA Expression in Alpha-1 Antitrypsin Deficient Monocytes Pre- and Post-AAT Augmentation Therapy

Stephen G. J. Smith, Catherine M. Greene

Summary: This study investigates the expression of long non-coding RNAs (lncRNAs) in alpha-1 antitrypsin (AAT) deficiency and explores the effect of AAT augmentation therapy on the lncRNA expression profile in ZZ monocytes. Results show that AAT augmentation therapy alters the expression of numerous lncRNAs in ZZ monocytes, and many of these changes are consistent with the effects observed in ZZ monocytes treated ex vivo with AAT. These findings provide insights into the potential mechanisms underlying the diverse effects of AAT augmentation therapy.

NON-CODING RNA (2023)

Article Biochemistry & Molecular Biology

Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency

Stefania Ottaviani, Giulia Bartoli, Tomas P. Carroll, Fabrizio Gangemi, Alice M. Balderacchi, Valentina Barzon, Alessandra Corino, Davide Piloni, Noel G. McElvaney, Angelo G. Corsico, James A. Irving, Annamaria Fra, Ilaria Ferrarotti

Summary: This study reports a panel of new SERPINA1 variants and describes their classification and clinical impact in individuals with AATD. The integration of computational, biochemical, and cellular studies was used to determine the associated risk of disease. The experimental results support the utility of the REVEL predictor in the initial assessment of newly identified AAT variants.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2023)

Review Respiratory System

Basic, translational and clinical aspects of bronchiectasis in adults

James D. Chalmers, Stuart Elborn, Catherine M. Greene

Summary: Bronchiectasis is a respiratory disease characterized by radiological abnormalities and a clinical syndrome of cough, sputum production, and recurrent respiratory infections. Inflammation, particularly neutrophilic inflammation, plays a central role in bronchiectasis pathophysiology. This article discusses the roles of infection, inflammation, and mucociliary clearance dysfunction in the development and progression of bronchiectasis. It also explores the concept of inflammatory endotypes and the potential of treating inflammation as a target. Current treatments for bronchiectasis focus on addressing underlying causes, improving mucociliary clearance, controlling infection, and managing complications. Additionally, the article discusses future therapies targeting host-mediated immune dysfunction.

EUROPEAN RESPIRATORY REVIEW (2023)

Editorial Material Genetics & Heredity

ncRNAs as biomarkers and therapeutic targets for bronchiectasis

Catherine M. Greene

EPIGENOMICS (2023)

Article Polymer Science

Star-shaped poly(l-lysine) with polyester bis-MPA dendritic core as potential degradable nano vectors for gene delivery

Smiljana Stefanovic, Katie McCormick, Sarinj Fattah, Ruiari Brannigan, Sally-Ann Cryan, Andreas Heise

Summary: A new synthetic route was developed to prepare star-shaped poly(l-lysine) from bis-MPA dendrimers. The resulting star polypeptides showed excellent degradability and were able to form polyplexes with nucleic acids for gene delivery.

POLYMER CHEMISTRY (2023)

Article Polymer Science

Exploring the potential of polypeptide-polypeptoide hybrid nanogels for mucosal delivery

Tao Xu, Dimitrios Skoulas, Dawei Ding, Sally-Ann Cryan, Andreas Heise

Summary: In this study, responsive biocompatible nanogels were synthesized for controlled mucosal delivery and release of drugs. The nanogels exhibited suitable size and morphology, and showed responsiveness to reducing agents in the intracellular environment. This work provides a new approach for drug delivery in anti-cancer therapy by overcoming mucosal barriers.

POLYMER CHEMISTRY (2022)

Article Medicine, Research & Experimental

A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 anti-trypsin for ARDS secondary to COVID-19

Oliver J. McElvaney, Natalie L. McEvoy, Fiona Boland, Oisin F. McElvaney, Grace Hogan, Karen Donnelly, Oisin Friel, Emmet Browne, Daniel D. Fraughen, Mark P. Murphy, Jennifer Clarke, Orna Ni Choileain, Eoin O'Connor, Rory McGuinness, Maria Boylan, Alan Kelly, John C. Hayden, Ann M. Collins, Ailbhe Cullen, Deirdre Hyland, Tomas P. Carroll, Pierce Geoghegan, John G. Laffey, Martina Hennessy, Ignacio Martin-Loeches, Noel G. McElvaney, Gerard F. Curley

Summary: This study reports the use of intravenous purified alpha-1 antitrypsin (AAT) in patients with COVID-19-related acute respiratory distress syndrome (ARDS). The results show that AAT treatment is safe, well-tolerated, and capable of reducing inflammation. Although the levels of IL-6 and sTNFR1 decreased in the treatment group, there was no definitive reduction in IL-113, IL-8, and IL-10 levels. While no difference in mortality or ventilator-free days was observed between groups, AAT-treated patients showed a trend towards reduced time on ventilator.
Article Respiratory System

Attitudes Towards Vaccination for Coronavirus Disease 2019 in Patients with Severe Alpha-1 Antitrypsin Deficiency

Oliver J. McElvaney, Brian Cleary, Daniel D. Fraughen, Geraldine Kelly, Mark P. Murphy, Oisin F. McElvaney, Peter Branagan, Cedric Gunaratnam, Tomas P. Carroll, Noel G. McElvaney

Summary: Patients with severe alpha-1 antitrypsin deficiency (AATD) have different motivations for COVID-19 vaccination based on their age, with older patients more concerned about illness and death while younger patients focus more on socializing. The motivation pattern of younger AATD patients is similar to non-deficient individuals of comparable age, while older patients align more closely with those with COPD.

CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION (2022)

Article Biochemistry & Molecular Biology

CENPL accelerates cell proliferation, cell cycle, apoptosis, and glycolysis via the MEK1/2-ERK1/2 pathway in hepatocellular carcinoma

Kun He, Mengyi Xie, Weifeng Hong, Yonghe Li, Yaolin Yin, Xiaojin Gao, Yi He, Yu Chen, Chuan You, Jingdong Li

Summary: Centromere protein L (CENPL) is overexpressed in hepatocellular carcinoma (HCC) and is associated with poor patient prognosis. Upregulation of CENPL promotes tumor proliferation and glycolysis in HCC cells by activating the MEK1/2-ERK1/2 signaling pathway.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2024)

Article Biochemistry & Molecular Biology

Talin mechanotransduction in disease

Yingzi Wang, Haozhong Huang, Huimin Weng, Chunsen Jia, Bin Liao, Yang Long, Fengxu Yu, Yongmei Nie

Summary: Talin protein plays a crucial role in transmitting mechanical forces by connecting the extracellular matrix to the cytoskeleton. It converts mechanical signals into biochemical signals and serves as diagnostic, therapeutic, and prognostic indicators in diseases.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2024)

Review Biochemistry & Molecular Biology

ER-mitochondria contact sites in mitochondrial DNA dynamics, maintenance, and distribution

Hema Saranya Ilamathi, Marc Germain

Summary: Mitochondria are the central metabolic hubs in cells, relying on proteins encoded by nuclear DNA and mitochondrial DNA (mtDNA) for their function. The maintenance and distribution of mtDNA are crucial for proper mitochondrial function and are associated with mitochondrial diseases. mtDNA is organized into nucleoids that dynamically move and interact with each other. The replication and distribution of mtDNA nucleoids are regulated by the complex interplay of mitochondrial dynamics, ER-mitochondria contact sites, and cytoskeletal networks.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2024)

Article Biochemistry & Molecular Biology

Tumor protein D52 (isoform 3) induces NF-κB-STAT3 mediated EMT driving neuroendocrine differentiation of prostate cancer cells

K. K. Sruthi, Sirisha Natani, Ramesh Ummanni

Summary: The overexpression of TPD52 is associated with the emergence of neuroendocrine prostate cancer (NEPC). TPD52 activates the NF-kappa B - STAT3 axis to induce neuroendocrine differentiation (NED) of prostate cancer cells. Therapeutic targeting of TPD52 is important for the treatment of prostate cancer.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2024)

Article Biochemistry & Molecular Biology

Tumor-derived microparticles promoted M2-like macrophages polarization to stimulate osteosarcoma progression

Cui Li, Feifan Xiang, Yuqi Gong, Yi Fu, Ge Chen, Zhi Wang, Zhong Li, Daiqing Wei

Summary: Our study demonstrates the significant role of tumor-derived microparticles (T-MPs) in osteosarcoma metastasis and immune response. T-MPs promote macrophage polarization and stimulate migration and chemoresistance of osteosarcoma cells, thereby affecting the progression of osteosarcoma.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2024)